REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Clinico de Salud Icsa S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Instituto Clinico de Salud Icsa S.A.S. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Clinico de Salud Icsa S.A.S. is based in Colombia, with the head office in Bucaramanga. It operates in the Diagnostic Imaging Centers industry. It was incorporated on October 25, 1993. It currently has a total number of 18 (2024) employees. There was a net sales revenue increase of 34.04% reported in Instituto Clinico de Salud Icsa S.A.S.’s latest financial highlights for 2023. Its total assets decreased by 12.82% over the same period. In, 2023, the company’s net profit margin increased by 0.26%.

Headquarters
Calle 39 # 22 - 62 - 48
Bucaramanga; Santander;

Contact Details: Purchase the Instituto Clinico de Salud Icsa S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Clinico de Salud Icsa S.A.S. report to view the information.
Outstanding Shares:
Purchase the Instituto Clinico de Salud Icsa S.A.S. report to view the information.
Incorporation Date:
October 25, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Clinico de Salud Icsa S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
34.04%
Total operating revenue
34.04%
Net Profit (Loss) for the Period
38.97%
Total assets
-12.82%
Total equity
-31.39%
Net Profit Margin
0.26%
Return on Equity (ROE)
15.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?